Earnings · China A-shares
Harbin Gloria Pharmaceuticals Co., Ltd. Class A (002437) earnings
Harbin Gloria Pharmaceuticals Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +1.80% year on year, +11.74% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -0.34% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +1.80%
- Excl. one-offs YoY
- +11.74%
- Net profit QoQ
- +39.18%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.37% | — |
| 3 days | -0.34% | — |
| 7 days | +5.15% | — |
| 14 days | -1.03% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -0.90%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥248.15M | +1.80% | +11.74% | -14.30% | 0.11 | 10.28% | -0.34% | — | — |
| 2026 interim report | 2026-08-27 | ¥158.99M | +18.27% | +22.24% | -8.41% | 0.07 | 7.18% | +5.56% | -20.77% | -11.84% |
| 2026 Q1 report | 2026-04-28 | ¥94.93M | +57.55% | +26.56% | -2.20% | 0.04 | 4.05% | -6.63% | -29.44% | -28.82% |
| 2025 annual report | 2026-04-28 | ¥376.91M | +61.93% | +8.64% | -12.51% | 0.17 | 18.00% | -6.63% | -29.44% | -28.82% |
| 2025 Q3 report | 2025-10-29 | ¥243.76M | +32.85% | +24.69% | -10.36% | 0.11 | 11.93% | +6.25% | -0.62% | +2.85% |
| 2025 interim report | 2025-08-27 | ¥134.42M | +7.56% | +13.28% | -9.97% | 0.06 | 6.78% | -5.25% | -11.05% | -14.83% |
| 2025 Q1 report | 2025-04-26 | ¥60.25M | +15.24% | +54.74% | -7.06% | 0.03 | 3.08% | -5.02% | +19.31% | +16.06% |
| 2024 annual report | 2025-04-26 | ¥232.76M | +93.43% | +243.42% | -7.06% | 0.11 | 12.89% | -5.02% | +19.31% | +16.06% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.